Bill > HRes394

This resolution expresses support for designating July 16, 2025, as "Glioblastoma Awareness Day" while highlighting the critical nature of this aggressive brain cancer. The resolution emphasizes that glioblastoma is the most common and deadly malignant brain tumor, with an estimated 13,000 Americans expected to be diagnosed in 2025 and over 10,000 projected to die from the disease annually. With a devastating 5-year survival rate of only 6.9% and a median survival of just 8 months, the resolution underscores the urgent need for increased research, awareness, and treatment development. The document calls for recognizing the challenges patients and caregivers face, including high medical costs and limited treatment options, with only 5 drugs and 1 medical device approved by the FDA since the 1920s. The resolution supports efforts to improve public understanding of glioblastoma, encourages collaborative research approaches, honors those affected by the disease, and promotes continued investment in research through networks like the Glioblastoma Therapeutics Network (GTN) to advance potential treatments and ultimately improve patient outcomes.

Business and Industry

https://www.congress.gov/bill/119th-congress/house-resolution/394/all-info